¥77.04
+
¥2.51 (3.37%)
End-of-day quote: 05/17/2024
SZSE:301047
Sino Biological Annual Report
| Year | Year | 2023 | 2022 | 2021 | ||
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥646.39M | ¥574.60M | ¥965.27M | |
| GM % | Gross Margin % |
|
80.53% | 83.47% | 92.85% | |
| OM | Operating Margin |
|
21.00% | 35.42% | 72.16% | |
| EPS | Earnings Per Share |
|
¥0.00 | ¥1.30 | ¥2.15 | ¥5.54 |
| Div. | Dividends |
|
¥2.00 | ¥2.00 | ¥5.26 | |
| PR % | Payout Ratio % |
|
153.85% | 93.02% | 94.95% | |
| Sha. | Shares |
|
129.2m | 129.2m | 129.2m | |
| OCF | Operating Cash Flow |
|
¥322.56M | ¥249.39M | ¥642.62M | |
| FCF | Free Cash Flow |
|
¥-720.80M | ¥93.33M | ¥594.72M | |
| FCFS | Free Cash Flow Per Share |
|
¥-5.58 | ¥0.82 | ¥5.52 |
